Literature DB >> 29442

Demonstration of enzymatic activity converting azathioprine to 6-mercaptopurine.

A Watanabe, N Hobara, H Nagashima.   

Abstract

The enzymatic conversion of azathioprine to 6-mercaptopurine was detected at pH 6.5 with rat liver supernatants, although the non-enzymatic reaction predominated at pH 7.0 and 7.5. Glutathione S-transferase may catalize this conversion. Activities of the enzyme in liver with both zathioprine and 1,2-dichloro-4-nitrobenzene as substrate decreased upon carbon tetrachloride-induced hepatic injury. These results may explain an ineffectiveness of azathioprine in patients with severe hepatic damage.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 29442

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  8 in total

Review 1.  Use of thiopurines in inflammatory bowel disease: Safety issues.

Authors:  Anastasia Konidari; Wael El Matary
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

Review 2.  Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.

Authors:  Gerassimos J Mantzaris
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

3.  Association of ITPA gene polymorphisms with adverse effects of AZA/6-MP administration: a systematic review and meta-analysis.

Authors:  Evaggelia Barba; Panagiota I Kontou; Ioannis Michalopoulos; Pantelis G Bagos; Georgia G Braliou
Journal:  Pharmacogenomics J       Date:  2022-01-17       Impact factor: 3.550

4.  Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

Review 5.  Use of thiopurines in inflammatory bowel disease.

Authors:  Pascal Frei; Luc Biedermann; Ole Haagen Nielsen; Gerhard Rogler
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

Review 6.  Toxicity mechanism-based prodrugs: glutathione-dependent bioactivation as a strategy for anticancer prodrug design.

Authors:  Xin-Yu Zhang; Adnan A Elfarra
Journal:  Expert Opin Drug Discov       Date:  2018-08-13       Impact factor: 6.098

Review 7.  Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics.

Authors:  Ji Young Chang; Jae Hee Cheon
Journal:  Dig Dis Sci       Date:  2019-07-09       Impact factor: 3.487

8.  Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.

Authors:  Christoph Thiel; Henrik Cordes; Isabel Conde; José Vicente Castell; Lars Mathias Blank; Lars Kuepfer
Journal:  Arch Toxicol       Date:  2016-05-09       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.